QP Release

Oral dosage forms (tablets, capsules, oral liquids)Actives and placebos

Primary and Secondary packaging and labelling capabilities 

https://eramol.com/clinical-services-category/clinical-packaging/

https://eramol.com/clinical-services-category/labelling-solutions/

Eramol specialises in early-phase sterile fill-finish, including aseptic processing, terminal sterilisation, sterile vial manufacturing, clinical packaging, UK & EU QP release and clinical trial supply.

Aseptic and Terminal sterilisation small molecule large molecule/biologics ADCs ATMPS...

Storage and global distribution capabilities 

https://eramol.com/clinical-services-category/clinical-storage-distribution/

Eramol’s new sterile manufacturing facility at its Sevenoaks campus is a purpose-built, EU GMP Annex 1 aligned site designed to support early-phase sterile injectable programmes. The facility features isolator-based aseptic fill-finish and terminal sterilisation, with phase-appropriate batch sizes and a strong focus on sterility assurance and product protection, achieving <1% line losses. Fully integrated with Eramol’s wider services, the facility provides an end-to-end sterile solution including packaging and labelling, QC testing, UK/EU QP release, regulatory support, GMP/GDP storage and global distribution, with planned expansion to support later-stage and commercial manufacturing.